ISV President’s Message

Linda S. Klavinskis, PhD (ISV President, 2024-2025)
Professor of Viral Immunology, Department of Infectious Diseases, King’s College London.

It is an honour and privilege to serve as President of the ISV, an association that brings together talented scientists from across the globe at all stages of their careers to exchange knowledge, sparks new ideas and inspires solutions to the most challenging human, animal, and One Health problems amenable to vaccine and immunotherapeutic interventions.

I would like to thank Dr Denise Doolan, the outgoing ISV President for her leadership during her term and congratulate Ted Gibson on assuming the position of Director of ISV Operations.  Read more…

ISV Upcoming Events

ISV’s Paper of the Month (POM)

July 2025

Immune correlates analysis of mRNA-1345 RSV vaccine efficacy clinical trial

AUTHORS
Chong Ma, et al.

ISV’s Paper of the Year (POY)

2024

Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates

AUTHORS
Atyeo C, Earl PL, Natarajan H, Santos G, Frey TR, Levin RH, Meni A, Arunkumar GA, Stadlbauer D, Jorquera PA, Bennett H, Johnson JC, Hardcastle K, Americo JL, Cotter CA, Koehler JW, Davis CI, Shamblin JD, Ostrowski K, Raymond JL, Ricks KM, Carfi A, Yu WH, Sullivan NJ, Moss B, Alter G, Hooper JW.

ISV Annual Supporters

info@isv-online.org  /  ISV Annual Congress